Backed by a world leading Group
In May 1996, JAC was acquired by Mediware Inc and continues to operate as a wholly owned subsidiary. The acquisition by Mediware Inc created the world’s largest specialist vendor of medicines management and pharmaceutical care software for hospitals. Mediware Inc. is a publicly quoted company on NASDAQ (code MEDW).
Mediware is a specialist provider of clinical information systems focused on complex areas of healthcare. Through our more than 25 years of experience, our focus has evolved from departmental systems residing in pharmacies and blood banks to broader clinical solutions that encapsulate the workflows of medication and blood management to deliver a ‘closed loop’ of information and process support – from the clinical professionals to the patient’s bedside.
This acquisition has had no direct affect on JAC’s operations and the business still operates with the original UK management, design and support team.
Mediware delivers blood and medication management software systems that encapsulate information supporting patient therapies, reinforce patient safety practices and improve efficiencies to lower costs. Mediware’s customers include prestigious hospitals, clinics, correctional institutions, blood centers and other public and private health care institutions throughout the world.
Mediware’s medication management suite of products includes the WORx pharmacy management software system that has been installed by many of the most prestigious hospitals in the United States. Other products include MediREC for medication reconciliation; MediMAR for bedside medication verification; MediCOE for electronic ordering.